Literature DB >> 24644076

Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease?

Srinivasan Dasarathy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24644076      PMCID： PMC4482450          DOI： 10.1002/hep.27134

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

1.  Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

Authors:  Masato Iwabu; Toshimasa Yamauchi; Miki Okada-Iwabu; Koji Sato; Tatsuro Nakagawa; Masaaki Funata; Mamiko Yamaguchi; Shigeyuki Namiki; Ryo Nakayama; Mitsuhisa Tabata; Hitomi Ogata; Naoto Kubota; Iseki Takamoto; Yukiko K Hayashi; Naoko Yamauchi; Hironori Waki; Masashi Fukayama; Ichizo Nishino; Kumpei Tokuyama; Kohjiro Ueki; Yuichi Oike; Satoshi Ishii; Kenzo Hirose; Takao Shimizu; Kazushige Touhara; Takashi Kadowaki
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

Review 2.  Mechanisms of regulation of the partition of fatty acids between oxidation and esterification in the liver.

Authors:  V A Zammit
Journal:  Prog Lipid Res       Date:  1984       Impact factor: 16.195

3.  Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6.

Authors:  Tahar Hajri; Huan Tao; Julia Wattacheril; Pamela Marks-Shulman; Naji N Abumrad
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-09       Impact factor: 4.310

4.  Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease.

Authors:  Kamran Qureshi; Ronald H Clements; Fahad Saeed; Gary A Abrams
Journal:  J Obes       Date:  2010-06-08

5.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

6.  Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

Authors:  Srinivasan Dasarathy; Takhar Kasumov; John M Edmison; Lourdes L Gruca; Carole Bennett; Clarita Duenas; Susan Marczewski; Arthur J McCullough; Richard W Hanson; Satish C Kalhan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052

7.  Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.

Authors:  Sabeera Bonala; Craig McFarlane; Jackie Ang; Radiance Lim; Marcus Lee; Hillary Chua; Sudarsanareddy Lokireddy; Patnam Sreekanth; Melvin Khee Shing Leow; Khoo Chin Meng; Tai E Shyong; Yung Seng Lee; Peter D Gluckman; Mridula Sharma; Ravi Kambadur
Journal:  Mol Endocrinol       Date:  2013-08-08

8.  Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-alpha, and PPAR-gamma expressions.

Authors:  Shana T N Suzuki; Baoping Zhao; Jinzeng Yang
Journal:  Biochem Biophys Res Commun       Date:  2008-02-27       Impact factor: 3.575

9.  The multi-level action of fatty acids on adiponectin production by fat cells.

Authors:  Shakun Karki; Partha Chakrabarti; Guanrong Huang; Hong Wang; Stephen R Farmer; Konstantin V Kandror
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

Review 10.  Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH).

Authors:  Akinobu Takaki; Daisuke Kawai; Kazuhide Yamamoto
Journal:  Int J Mol Sci       Date:  2013-10-15       Impact factor: 5.923
View more
  10 in total

Review 1.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

2.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

3.  The Role of Promyelocytic Leukemia Protein in Steatosis-Associated Hepatic Tumors Related to Chronic Hepatitis B virus Infection.

Authors:  Yih-Lin Chung; Mei-Ling Wu
Journal:  Transl Oncol       Date:  2018-04-24       Impact factor: 4.243

4.  Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.

Authors:  Jinmi Lee; Seok-Woo Hong; Min-Jeong Kim; Sun Joon Moon; Hyemi Kwon; Se Eun Park; Eun-Jung Rhee; Won-Young Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-09

5.  Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Liu Han; Shifeng Fu; Jianglei Li; Deliang Liu; Yuyong Tan
Journal:  Front Med (Lausanne)       Date:  2022-08-26

Review 6.  The Common Mechanisms of Sarcopenia and NAFLD.

Authors:  Yu Zhai; Qian Xiao
Journal:  Biomed Res Int       Date:  2017-12-13       Impact factor: 3.411

7.  Treatment of Diabetic Mice with a Combination of Ketogenic Diet and Aerobic Exercise via Modulations of PPARs Gene Programs.

Authors:  Qiang Zhang; Lingyan Xu; Jie Xia; Dongmei Wang; Min Qian; Shuzhe Ding
Journal:  PPAR Res       Date:  2018-03-20       Impact factor: 4.964

8.  IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.

Authors:  Huijie Shi; Qingchun Wang; Liu Yang; Shouxia Xie; Haibo Zhu
Journal:  FEBS Open Bio       Date:  2017-08-29       Impact factor: 2.693

9.  AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis.

Authors:  Hongjiao Xu; Qian Zhao; Nazi Song; Zhibin Yan; Runfeng Lin; Shuohan Wu; Lili Jiang; Sihua Hong; Junqiu Xie; Huihao Zhou; Rui Wang; Xianxing Jiang
Journal:  Nat Commun       Date:  2020-11-16       Impact factor: 14.919

Review 10.  An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.

Authors:  Young Joo Yang; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.